Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2
作者单位:Proteomics Unit, CIC BioGUNE and Biochemistry Department, Bizkaia Technology Park, 48160 Derio, Spain[1]Dept. Microbiología II, Fac. Farmacia, Universidad Complutense de Madrid, Pza Ramón y Cajal, 28040 Madrid, Spain[2]Centro Nacional de Biotecnología, CSIC, Campus Universidad Autónoma de Madrid, 28049 Madrid, Spain[3]